|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02361 SINOHEALTH HLDG
Nominal 
3.240 +0.020 (+0.621%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 147,925 | -7.275% | 403,728 | 396,194 | 356,668 | 324,166 |
| Cost of Sales | (65,823) | -6.955% | (170,527) | (172,722) | (197,560) | (131,527) |
| Gross Profit | 82,102 | -7.530% | 233,201 | 223,472 | 159,108 | 192,639 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,016) | -82.253% | (12,861) | (24,079) | (2,678) | (2,855) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | (416) | |
| Profit / (Loss) before Taxation | 26,155 | -38.522% | 120,148 | 110,741 | 54,474 | 95,529 | |
| Taxation | (1,644) | 738.776% | (8,325) | (9,801) | (261) | (23,551) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 233 | -- | (1,174) | 1,092 | 1,545 | 6,835 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 24,744 | -40.626% | 110,649 | 102,032 | 55,758 | 78,813 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (11,600) | -11.592% | (25,671) | (26,028) | (6,203) | 284 |
| Depreciation & Amortisation | 4,276 | 7.789% | 8,044 | 8,566 | 8,729 | 7,352 |
| Directors' Emoluments | -- | -- | 3,826 | 2,306 | 1,981 | 1,376 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 6.000 | -40.000% | 26.970 | 23.940 | 13.580 | 21.120 |
| DPS (cts) | 0.000 | -- | 19.986 | 6.574 | 3.493 | -- |
| Dividend Payout Ratio (%) | -- | -- | 74.103% | 27.461% | 25.720% | -- |
| Cash flow per share ($) | -- | -- | 0.224 | 0.186 | 0.079 | 0.161 |
| NBV per share ($) | 1.514 | -- | 1.573 | 1.557 | 1.538 | -- |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 24,744 |
| %Change | -40.626% |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB 1.514 |